Crossmark

Application of the Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide the empiric antibiotic treatment of febrile neutropenia in oncological paediatric patients: experience from two paediatric hospitals in Northern Italy

Crossref DOI link: https://doi.org/10.1186/s12941-024-00673-8

Published Online: 2024-02-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liberati, Cecilia

Donà, Daniele

Maestri, Linda

Petris, Maria Grazia

Barbieri, Elisa

Gallo, Elisa

Gallocchio, Jacopo

Pierobon, Marta

Calore, Elisabetta

Zin, Annachiara

Brigadoi, Giulia

Mariani, Marcello

Mesini, Alessio

Saffioti, Carolina

Ugolotti, Elisabetta

Gregori, Dario

Giaquinto, Carlo

Castagnola, Elio

Biffi, Alessandra
Funding

Funding for this research was provided by:

Università degli Studi di Padova
License Information

Text and Data Mining valid from 2024-02-15

Version of Record valid from 2024-02-15
More Information

Article History

Received: 3 August 2023

Accepted: 30 January 2024

First Online: 15 February 2024

Declarations

:

: The present study was approved by the Ethic Committee for the clinical sperimentation of Padua, code AOP0790.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below